ID vaccination

Intradermal vaccination

9b74c44e62-IDAL Translucent inside springs2In modern pig production the pig producers often control more specialized units. In order to manage and control the herd health situation easily and efficiently, there is a need for systems and methods that are fast and reliable. The modern consumer demands food that is free of residues and consequential damages, whether arising from drugs or vaccines. Intradermal administration of vaccines combines both the needs of consumers for safe food as well as farmers' demand for an efficient, user-friendly and easy vaccination method in the herd.

Immune response induced by intradermal vaccination

Vaccine deposit

By intradermal vaccination, the vaccine is deposited in the pig’s dermis. IDAL ensures that the vaccine triggers a strong vaccine response from the dendritic cells.

 

Effective immune response

Studies have shown that intradermal vaccination using the needleless syringe capable of inducing a strong humoral and cellular immune response of at least the same strength as in conventional intramuscular vaccination1

Benefits for the pig

  • Small injection volumes (0.2 ml)
  • Less pain1
  • Improved animal welfare
  • No risk of broken needles
  • No damage to the muscle tissue
  • Strong immune response1
  • Minimal risk of disease transmission between pigs
  • The vaccine is not inhibited by antibodies from the sow colostrum2

Benefit for the user

  • User friendly1
  • Increased flexibility in the choice of vaccination area3
  • Vaccination requires minimal physical effort4
  • High-performance battery
  • Can give more than 1000 doses per battery charge
  • Large number of pigs to be vaccinated in a short period of time


1) Ferrari L. et al. (2011). Evaluation of the immune response induced by intradermal vaccination by using a needleless system in comparison with the intramuscular route in conventional pigs. Research in Veterinary Science 90 64-71.
2) Visser, N., Egger, W. and Lütticken, D. (1994). Intradermal application of Aujeszkey’s disease virus strain Begonia with tocopherol-based adjuvant and a novel design injection device. Acta Veterinaria Hungarica 42 (2-3), pp. 413-418
3) Bekendtgørelse nr. 780 af 24/06/201 §8 – Bekendtgørelse om dyreejers anvendelser af lægemidler til dyr samt offentlig egenkontrol med restkoncentrationer.
4) Tassis, P.D. et al. (2002). Clinical evaluation of intradermal vaccination against porcine inzootic pneumonia (Mycoplasma Hyopneumoniae). Veterinary Record, published online doi: 10.1136/vr. 100239
5)Baker, S. R et. al. (2012). Evaluation of a needle-free injection device to prevent hematogenous transmission of porcine reproductive and respiratory syndrome virus. Journal of Swine Health and Production. Vol. 20. No. 3. 123-128.